KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 17 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $10,456,000 | -59.1% | 10,000,000 | -60.0% | 0.04% | -66.1% |
Q1 2021 | $25,538,000 | -41.3% | 25,000,000 | -28.6% | 0.13% | -51.5% |
Q4 2020 | $43,527,000 | -6.8% | 35,000,000 | -9.1% | 0.26% | -18.9% |
Q3 2020 | $46,694,000 | -7.1% | 38,523,000 | +9.7% | 0.32% | -19.7% |
Q2 2020 | $50,287,000 | +1.7% | 35,102,000 | 0.0% | 0.40% | -5.4% |
Q1 2020 | $49,460,000 | +43.7% | 35,102,000 | +46.3% | 0.42% | +83.2% |
Q4 2019 | $34,430,000 | – | 24,000,000 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |